MANDARIN (S6371)

Clinical trial NCT05016245 · COMPLETED

Trial details

NCT number: NCT05016245
Sponsor: Boston Scientific Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Inoperable Hepatocellular Carcinoma

Start date: 2021-09-13
Primary completion: 2026-02-13
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.